INTU
51
2
HRB
51
2
EOG
58
2
PPL
54
2
JPM
63
-4
HUM
48
6
CVS
48
3
AKAM
43
3
HCP
58
4
NWSA
62
2
IVZ
46
3
EXC
54
-2
CVX
46
5
A
36
2
HSIC
54
-3
DVA
72
2
NTAP
64
2
EQT
59
2
VTR
49
-3
MUR
43
3
INTU
51
2
HRB
51
2
EOG
58
2
PPL
54
2
JPM
63
-4
HUM
48
6
CVS
48
3
AKAM
43
3
HCP
58
4
NWSA
62
2
IVZ
46
3
EXC
54
-2
CVX
46
5
A
36
2
HSIC
54
-3
DVA
72
2
NTAP
64
2
EQT
59
2
VTR
49
-3
MUR
43
3
Financhill
Back

Iovance Biotherapeutics Vs. Perspective Therapeutics Industry Stock Comparison

Sell
32

IOVA
Iovance Biotherapeutics

Last Price:
8.25
Seasonality Move:
16.76%
Sell
30

CATX
Perspective Therapeutics

Last Price:
2.99
Seasonality Move:
34.33%
Sell
32
Iovance Biotherapeutics (IOVA) is a Sell

Is Iovance Biotherapeutics a Buy, Sell or Hold?

  • The current Iovance Biotherapeutics [IOVA] share price is $8.14. The Score for IOVA is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • IOVA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $6.17. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

IOVA Stock Price Chart

What is Iovance Biotherapeutics's stock price today?

  • The Iovance Biotherapeutics share price today is $8.14
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IOVA is experiencing slight selling pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $6.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

IOVA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 33.64 Sell
Chaikin Money Flow: -854109 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.96 - 11.36) Sell
Bollinger Bands (100): (8.43 - 10.93) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.47 Sell
Relative Strength Index (14 RSI): 14.63 Sell
Chaikin Money Flow: -723713 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.98 - 12.88) Sell
Bollinger Bands (100): (10.81 - 14.53) Sell

IOVA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.86 Sell
20-day SMA: 10.24 Sell
50-day SMA: 9.96 Sell
200-day SMA: 10.77 Sell
8-day EMA: 8.88 Sell
20-day EMA: 9.66 Sell
50-day EMA: 9.92 Sell
200-day EMA: 9.76 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.55 Sell
20-day SMA: 10.54 Sell
50-day SMA: 12.08 Sell
200-day SMA: 12.78 Sell
8-day EMA: 8.2 Sell
20-day EMA: 9.96 Sell
50-day EMA: 11.52 Sell
200-day EMA: 11.52 Sell

Iovance Biotherapeutics Earnings Growth & IOVA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.58 per share, and an increase next year of $0.48 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

Iovance Biotherapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):